Volume 13 Issue 4
Jul.  2022
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2022  >  13(4): 489-494
Lai Man, Wang Xin, Yao Qinwei, et al. Predictive value of the initial MELD score and its derivative scores for early survival rate after liver transplantation in patients with liver failure[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 489-494. doi: 10.3969/j.issn.1674-7445.2022.04.012
Citation: Lai Man, Wang Xin, Yao Qinwei, et al. Predictive value of the initial MELD score and its derivative scores for early survival rate after liver transplantation in patients with liver failure[J]. ORGAN TRANSPLANTATION, 2022, 13(4): 489-494. doi: 10.3969/j.issn.1674-7445.2022.04.012
shu

Predictive value of the initial MELD score and its derivative scores for early survival rate after liver transplantation in patients with liver failure

doi: 10.3969/j.issn.1674-7445.2022.04.012

  • Department of Critical Care Medicine, Beijing You'an Hospital, Capital Medical University, Beijing 100069, China

More Information
  • Corresponding author: Li Guangming, Email: liguangming917@163.com
  • Received Date: 2022-02-14
    Available Online: 2022-07-14
  • Publish Date: 2022-07-15
    Abstract
  •   Objective  To explore the predictive values of the initial model for end-stage liver disease (MELD) score, MELD combined with serum sodium (MELD-Na) score and MELD combined with serum lactic acid (MELD-Lac) score for early survival rate after liver transplantation in patients with liver failure.  Methods  Clinical data of 135 recipients undergoing liver transplantation for liver failure were retrospectively analyzed. All patients were divided into the early survival group (n=110) and early death group (n=25) according to the survival at postoperative 28 d. Clinical data were compared between two groups. The optimal cut-off values of MELD, MELD-Na and MELD-Lac scores for predicting early survival rate after liver transplantation in patients with liver failure were determined by the receiver operating characteristic (ROC) curve. The predictive values of different scores for early survival rate after liver transplantation in patients with liver failure were evaluated.  Results  Significant differences were observed in the initial MELD, MELD-Na and MELD-Lac scores after liver transplantation between two groups (all P < 0.05). For the initial MELD, MELD-Na and MELD-Lac scores in predicting early survival rate after liver transplantation in patients with liver failure, the AUC were 0.653 [95% confidence interval (CI) 0.515-0.792], 0.648 (95%CI 0.514-0.781) and 0.809 (95%CI 0.718-0.900), the optimal cut-off values were 18.09, 18.09 and 19.97, Youden's indexes were 0.398, 0.380 and 0.525, the sensitivity was 0.680, 0.680 and 0.840, and the specificity was 0.720, 0.700 and 0.690, respectively. The AUC of MELD-Lac score was higher than those of MELD and MELD-Na scores, and the differences were statistically significant (both P < 0.05).  Conclusions  Compared with the initial MELD and MELD-Na scores after liver transplantation, the initial MELD-Lac score is a more reliable index for predicting early survival rate after liver transplantation in patients with liver failure.

     

    • FullText(HTML)
  • loading
    • References(32)
  • [1]
    中华医学会器官移植学分会围手术期管理学组. 肝衰竭肝移植围手术期管理中国专家共识(2021版)[J]. 中华消化外科杂志, 2021, 20(8): 835-840. DOI: 10.3760/cma.j.cn115610-20210626-00312.

    Perioperative Management Group of Branch of Organ Transplantation of Chinese Medical Association. Chinese expert consensus on perioperative management of liver transplantation in patients with liver failure (2021 edition)[J]. Chin J Dig Surg, 2021, 20(8): 835-840. DOI: 10.3760/cma.j.cn115610-20210626-00312.
    [2]
    CZIGANY Z, SCHERER MN, PRATSCHKE J, et al. Technical aspects of orthotopic liver transplantation-a survey-based study within the Eurotransplant, Swisstransplant, Scandiatransplant, and British Transplantation Society networks[J]. J Gastrointest Surg, 2019, 23(3): 529-537. DOI: 10.1007/s11605-018-3915-6.
    [3]
    中华医学会感染病学分会肝衰竭与人工肝学组, 中华医学会肝病学分会重型肝病与人工肝学组. 肝衰竭诊治指南(2018年版)[J]. 临床肝胆病杂志, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.

    Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure (2018)[J]. J Clin Hepatol, 2019, 35(1): 38-44. DOI: 10.3969/j.issn.1001-5256.2019.01.007.
    [4]
    张冬青, 郑瑞丹, 林明华, 等. HBV相关慢加急性肝衰竭患者90天预后影响因素分析[J]. 临床肝胆病杂志, 2021, 37(10): 2316-2319. DOI: 10.3969/j.issn.1001-5256.2021.10.011.

    ZHANG DQ, ZHENG RD, LIN MH, et al. Influencing factors for the 90-day prognosis of patients with HBV-related acute-on-chronic liver failure[J]. J Clin Hepatol, 2021, 37(10): 2316-2319. DOI: 10.3969/j.issn.1001-5256.2021.10.011.
    [5]
    CARDOSO NM, SILVA T, BASILE-FILHO A, et al. A new formula as a predictive score of post-liver transplantation outcome: postoperative MELD-lactate[J]. Transplant Proc, 2014, 46(5): 1407-1412. DOI: 10.1016/j.transproceed.2013.12.067.
    [6]
    BELLI LS, DUVOUX C, ARTZNER T, et al. Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS)[J]. J Hepatol, 2021, 75(3): 610-622. DOI: 10.1016/j.jhep.2021.03.030.
    [7]
    YOON JU, YOO YM, BYEON GJ, et al. The impact of pretransplant hepatic encephalopathy, model for end-stage liver disease (MELD) scale on long-term survival following deceased donor liver transplantation: a retrospective study[J]. Ann Palliat Med, 2021, 10(5): 5171-5180. DOI: 10.21037/apm-21-21.
    [8]
    RAMZAN M, IQBAL A, MURTAZA HG, et al. Comparison of CLIF-C ACLF score and MELD score in predicting ICU mortality in patients with acute-on-chronic liver failure[J]. Cureus, 2020, 12(2): e7087. DOI: 10.7759/cureus.7087.
    [9]
    VERMA R, JAIN N, ARORA A, et al. Beyond MELD predictors of post TIPSS acute liver failure the lesson learned[J]. Indian J Radiol Imaging, 2021, 31(3): 618-622. DOI: 10.1055/s-0041-1736403.
    [10]
    BOECKER J, CZIGANY Z, BEDNARSCH J, et al. Potential value and limitations of different clinical scoring systems in the assessment of short- and long-term outcome following orthotopic liver transplantation[J]. PLoS One, 2019, 14(3): e0214221. DOI: 10.1371/journal.pone.0214221.
    [11]
    KLEIN KB, STAFINSKI TD, MENON D. Predicting survival after liver transplantation based on pre-transplant MELD score: a systematic review of the literature[J]. PLoS One, 2013, 8(12): e80661. DOI: 10.1371/journal.pone.0080661.
    [12]
    ACAR Ş, AKYILDIZ M, GÜRAKAR A, et al. Delta MELD as a predictor of early outcome in adult-to-adult living donor liver transplantation[J]. Turk J Gastroenterol, 2020, 31(11): 782-789. DOI: 10.5152/tjg.2020.18761.
    [13]
    GOUDSMIT BFJ, BRAAT AE, TUSHUIZEN ME, et al. Joint modeling of liver transplant candidates outperforms the model for end-stage liver disease: the effect of disease development over time on patient outcome[J]. Am J Transplant, 2021, 21(11): 3583-3592. DOI: 10.1111/ajt.16730.
    [14]
    KIM JD, CHOI JY, KWON JH, et al. Performance of posttransplant model for end-stage liver disease (MELD) and delta-MELD scores on short-term outcome after living donor liver transplantation[J]. Transplant Proc, 2009, 41(9): 3766-3768. DOI: 10.1016/j.transproceed.2009.10.006.
    [15]
    POMMERGAARD HC, DAUGAARD TR, ROSTVED AA, et al. Model for end-stage liver disease score predicts complications after liver transplantation[J]. Langenbecks Arch Surg, 2021, 406(1): 55-65. DOI: 10.1007/s00423-020-02018-3.
    [16]
    KHANDOGA A, ISKANDAROV E, ANGELE M, et al. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome[J]. Eur J Gastroenterol Hepatol, 2016, 28(2): 153-158. DOI: 10.1097/MEG.0000000000000505.
    [17]
    WAGENER G, RAFFEL B, YOUNG AT, et al. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score[J]. Liver Transpl, 2013, 19(5): 534-542. DOI: 10.1002/lt.23634.
    [18]
    KAMATH PS, KIM WR, Advanced Liver Disease Study Group. The model for end-stage liver disease (MELD)[J]. Hepatology, 2007, 45(3): 797-805. DOI: 10.1002/hep.21563.
    [19]
    SACLEUX SC, SAMUEL D. A critical review of MELD as a reliable tool for transplant prioritization[J]. Semin Liver Dis, 2019, 39(4): 403-413. DOI: 10.1055/s-0039-1688750.
    [20]
    KIM Y, KIM K, JANG I. Analysis of mortality prognostic factors using model for end-stage liver disease with incorporation of serum-sodium classification for liver cirrhosis complications: a retrospective cohort study[J]. Medicine (Baltimore), 2019, 98(45): e17862. DOI: 10.1097/MD.0000000000017862.
    [21]
    SHARMA P, SCHAUBEL DE, GOODRICH NP, et al. Serum sodium and survival benefit of liver transplantation[J]. Liver Transpl, 2015, 21(3): 308-313. DOI: 10.1002/lt.24063.
    [22]
    GOUDSMIT BFJ, PUTTER H, TUSHUIZEN ME, et al. Validation of the model for end-stage liver disease sodium (MELD-Na) score in the Eurotransplant region[J]. Am J Transplant, 2021, 21(1): 229-240. DOI: 10.1111/ajt.16142.
    [23]
    KRAMER A, AL AGHA S, BÖHM L, et al. Lactate in emergency medicine[J]. Anaesthesist, 2020, 69(11): 826-834. DOI: 10.1007/s00101-020-00819-1.
    [24]
    VITIN AA, AZAMFIREI L, TOMESCU D, et al. Perioperative management of lactic acidosis in end-stage liver disease patient[J]. J Crit Care Med (Targu Mures), 2017, 3(2): 55-62. DOI: 10.1515/jccm-2017-0014.
    [25]
    AGRAWAL T, MAIWALL R, RAJAN V, et al. Higher circulating natural killer cells and lower lactate levels at admission predict spontaneous survival in non-acetaminophen induced acute liver failure[J]. Clin Immunol, 2021, 231: 108829. DOI: 10.1016/j.clim.2021.108829.
    [26]
    CARDOSO FS, ABRALDES JG, SY E, et al. Lactate and number of organ failures predict intensive care unit mortality in patients with acute-on-chronic liver failure[J]. Liver Int, 2019, 39(7): 1271-1280. DOI: 10.1111/liv.14083.
    [27]
    SARMAST N, OGOLA GO, KOUZNETSOVA M, et al. Model for end-stage liver disease-lactate and prediction of inpatient mortality in patients with chronic liver disease[J]. Hepatology, 2020, 72(5): 1747-1757. DOI: 10.1002/hep.31199.
    [28]
    MAHMUD N, ASRANI SK, KAPLAN DE, et al. The predictive role of model for end-stage liver disease-lactate and lactate clearance for in-hospital mortality among a national cirrhosis cohort[J]. Liver Transpl, 2021, 27(2): 177-189. DOI: 10.1002/lt.25913.
    [29]
    POPESCU M, DIMA S, BRASOVEANU V, et al. High perioperative lactate levels and decreased lactate clearance are associated with increased incidence of posthepatectomy liver failure[J]. Hepatobiliary Pancreat Dis Int, 2021, 20(6): 592-594. DOI: 10.1016/j.hbpd.2021.03.005.
    [30]
    GOLSE N, GUGLIELMO N, EL METNI A, et al. Arterial lactate concentration at the end of liver transplantation is an early predictor of primary graft dysfunction[J]. Ann Surg, 2019, 270(1): 131-138. DOI: 10.1097/SLA.0000000000002726.
    [31]
    FERNÁNDEZ-SARMIENTO J, WILCHES-CUADROS MA, HERNANDEZ-SARMIENTO R, et al. Association between serum lactate and unsatisfactory outcomes in critically ill children in the immediate post-operative period of liver transplantation[J]. Front Pediatr, 2022, 9: 796504. DOI: 10.3389/fped.2021.796504.
    [32]
    MARTINS RM, TEODORO JS, FURTADO E, et al. Evaluation of bioenergetic and mitochondrial function in liver transplantation[J]. Clin Mol Hepatol, 2019, 25(2): 190-198. DOI: 10.3350/cmh.2018.0087.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)  / Tables(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (303) PDF downloads(69) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return